CIK 0001818382 · Non-accelerated filer<br>Smaller reporting company
Humacyte, Inc.
Sign in to watch- Ticker
- HUMA
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 851763759
- Phone
- 919-313-9633
- Business address
- 2525 EAST NORTH CAROLINA HIGHWAY 54, DURHAM, NC, 27713
- Former names
- Alpha Healthcare Acquisition Corp.
- Open-market buys, last 90 days
- $30,370
- in 3 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Net +$30,370. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2021-11-22 | Constantino Michael T. Director | Purchase | +2,300 | $10.79 | $25K | 2,500 |
| 2021-10-13 | Scheessele William John Chief Commercial Officer | Grant or award · Stock Options (right to buy) | +157,558 | 157,558 | ||
| 2021-10-13 | Binder Gordon M Director | Grant or award · Stock Options (right to buy) | +13,000 | 13,000 | ||
| 2021-10-13 | Brown Emery N. Director | Grant or award · Stock Options (right to buy) | +13,000 | 13,000 | ||
| 2021-10-13 | Constantino Michael T. Director | Grant or award · Stock Options (right to buy) | +13,000 | 13,000 | ||
| 2021-10-13 | Dougan Brady W Director | Grant or award · Stock Options (right to buy) | +8,500 | 8,500 | ||
| 2021-10-13 | Niklason Laura E President, CEO and Director | Grant or award · Stock Options (right to buy) | +8,500 | 8,500 | ||
| 2021-10-13 | Pope Todd Director | Grant or award · Stock Options (right to buy) | +13,000 | 13,000 | ||
| 2021-10-13 | Sebelius Kathleen Director | Grant or award · Stock Options (right to buy) | +8,500 | 8,500 | ||
| 2021-10-13 | Shukla Rajiv Director | Grant or award · Stock Options (right to buy) | +13,000 | 13,000 | ||
| 2021-10-13 | Wallace Max N. Director | Grant or award · Stock Options (right to buy) | +8,500 | 8,500 | ||
| 2021-10-13 | Windham-Bannister Susan Richards Director | Grant or award · Stock Options (right to buy) | +13,000 | 13,000 | ||
| 2021-08-26 | Niklason Laura E President, CEO and Director | Grant or award | +1,148,240 | 1,148,240 | ||
| 2021-08-26 | Niklason Laura E President, CEO and Director | Grant or award | +18,930,004 | 18,930,004 | ||
| 2021-08-26 | Niklason Laura E President, CEO and Director | Purchase | +1,522,500 | $10.00 | $15.2M | 20,452,504 |
| 2021-08-26 | Niklason Laura E President, CEO and Director | Grant or award · Stock Options (right to buy) | +262,596 | 262,596 | ||
| 2021-08-26 | Niklason Laura E President, CEO and Director | Grant or award · Stock Options (right to buy) | +13,129 | 13,129 | ||
| 2021-08-26 | Niklason Laura E President, CEO and Director | Grant or award · Stock Options (right to buy) | +157,558 | 157,558 | ||
| 2021-08-26 | Niklason Laura E President, CEO and Director | Grant or award · Stock Options (right to buy) | +262,596 | 262,596 | ||
| 2021-08-26 | Niklason Laura E President, CEO and Director | Grant or award · Stock Options (right to buy) | +131,298 | 131,298 |
Page 14 of 17 · 330 trades